Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00475709 · ClinicalTrials.gov registry record · NA

Aortic Valve Replacement With Trifecta(TM)

A NA study of Aortic Valve Stenosis and Aortic Valve Insufficiency, sponsored by Abbott Medical Devices.

Completed
Registry status
NA
Development phase
1,022
Enrollment target
18
Study locations

NCT00475709 is a NA study of Aortic Valve Stenosis and Aortic Valve Insufficiency that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,022 participants, roughly in line with the 1,009-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target. The trial reports 18 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00475709, a NA study of Aortic Valve Stenosis and Aortic Valve Insufficiency, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
NA
Development phase
1,022 participants
Enrollment target
18
Study locations

Study Summary

To confirm the clinical safety and effectiveness of the Trifecta valve.

Interventions

  • DEVICE Trifecta Aortic Heart Valve

Study Locations (18)

Minnesota

  • Abbott Northwestern Hospital - Minneapolis
  • Mayo Clinic - Rochester

New York

  • NYU Medical Center - New York
  • Columbia University Medical Center - New York

North Carolina

  • Mission Hospitals - Asheville
  • Duke University Medical Center - Durham

Pennsylvania

  • University of Pennsylvania Health System - Philadelphia
  • Main Line Health Heart Center - Wynnewood

Texas

  • Cardiothoracic and Vascular Surgeons - Austin
  • Baylor College of Medicine - Houston

California

  • USC Keck School of Medicine, Dept. of Cardiothoracic Surgery, USC University Hospital - Los Angeles

Florida

  • Sarasota Memorial Hospital/Clinical Research Center - Sarasota

Illinois

  • Loyola University Medical Center - Maywood

Trial Details

FieldValue
Enrollment Target 1,022 participants
Start Date 2007-06
Est. Completion 2012-01
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

What the Registry Record Tells You About NCT00475709

The ClinicalTrials.gov registry entry for NCT00475709 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,022 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,009-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Aortic Valve Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Trifecta Aortic Heart Valve is the first listed.

NCT00475709 reports 18 study locations spanning 13 distinct geographic areas - top geographies include Minnesota, New York, North Carolina.

Frequently Asked Questions

What is clinical trial NCT00475709 about?

NCT00475709 is a clinical study titled "Aortic Valve Replacement With Trifecta(TM)". To confirm the clinical safety and effectiveness of the Trifecta valve.

What is the current status of trial NCT00475709?

This trial is currently completed. It is a NA study. The enrollment target is 1,022 participants. The study started on 2007-06. Estimated completion is 2012-01.

What conditions does trial NCT00475709 study?

This clinical trial studies the following conditions: Aortic Valve Stenosis, Aortic Valve Insufficiency, Regurgitation, Aortic Valve, Aortic Valve Incompetence.

What interventions are being tested in trial NCT00475709?

The interventions under investigation include: Trifecta Aortic Heart Valve (DEVICE).

Who is sponsoring clinical trial NCT00475709?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00475709 being conducted?

This trial has 18 study locations across California, Florida, Illinois, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aortic Valve Stenosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.